India to Cameroon: Albendazole Export Trade Route
India has recorded 163 verified shipments of Albendazole exported to Cameroon, representing a combined trade value of $2.8M USD. This corridor is served by 55 active Indian exporters, with an average shipment value of $17.3K USD. The leading Indian exporter is KROSYL PHARMACEUTICALS PRIVATE LIMITED, which accounts for 59% of total export value with 2 shipments worth $1.7M USD. On the buying side, TO THE ORDER (CAMEROON is the largest importer in Cameroon with $1.7M USD in purchases. The top 3 suppliers — KROSYL PHARMACEUTICALS PRIVATE LIMITED, ZEE LABORATORIES, LANARK LABORATORIES PVT LTD — together control 72% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Cameroon Albendazole corridor is one of India's established pharmaceutical export routes, with 163 shipments documented worth a combined $2.8M USD. The route is dominated by KROSYL PHARMACEUTICALS PRIVATE LIMITED, which alone accounts for roughly 59% of all export value, reflecting the consolidated nature of India's albendazole manufacturing sector.
Across 55 active suppliers, the average shipment value stands at $17.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 71% of all shipments, consistent with albendazole's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 19 days port-to-port. The route has recorded an annual growth rate of 13.6%, placing it at rank #13 among India's top albendazole export destinations globally.
On the import side, key buyers of Indian albendazole in Cameroon include TO THE ORDER (CAMEROON, SCA PHARMA SARL, K-PHARMA and 57 others. TO THE ORDER (CAMEROON is the single largest importer with 2 shipments valued at $1.7M USD.
